Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS vs Merck & Company: Fair Value & Quality
Both stocks run through our valuation models. Here is how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) and Merck & Company (MRK) compare, as of Sep 23, 2026.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Merck & Company leads: 5 to 10 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
What the models say
How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.
▲above the price, more than 15% above ●close to the price, 85% to 115% of the price ▼below the price, more than 15% below
| Model family | Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret ASPrice TRY 7.48 | Merck & CompanyPrice $151 |
|---|---|---|
| DCF Models | ●+2%close to the priceTRY 7.63 | ▼-22%below the price$117 |
| Earnings-Based | ▼-15%below the priceTRY 6.35 | ▼-58%below the price$62.77 |
| Dividend Discount | n/a | ▼-60%below the price$60.35 |
| Multiples | ▼-26%below the priceTRY 5.56 | ▼-19%below the price$122 |
| Asset-Based | ▼-79%below the priceTRY 1.54 | ▼-91%below the price$14.27 |
| Growth DCF | ●-10%close to the priceTRY 6.75 | ▼-51%below the price$74.00 |
| Economic Profit | ▼-16%below the priceTRY 6.32 | ▼-44%below the price$83.85 |
| Growth Earnings | ●+13%close to the priceTRY 8.43 | ●-8%close to the price$138 |
| Minimum | ▼-79%below the priceTRY 1.54 | ▼-91%below the price$14.27 |
| Maximum | ●+13%close to the priceTRY 8.43 | ●-8%close to the price$138 |
| Median | ▼-15%below the priceTRY 6.35 | ▼-48%below the price$78.93 |
| Geometric mean | ▼-27%below the priceTRY 5.48 | ▼-53%below the price$71.25 |
Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS: 14 of 24 models see the stock below the current price.
Merck & Company: 24 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS · Health Care
Merck & Company · Health Care
Bottom line
As of Sep 23, 2026, Fair Value Calculator sees Merck & Company as the less overvalued of the two: Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS trades at TRY 7.48 versus a fair value of TRY 3.99 (-47%), while Merck & Company trades at $151 versus $125 (-17%).
Merck & Company has the higher quality score (70/100).
Open Merck & Company live analysis →More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Related to Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor ManufacturingSee the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.